Method Development
AXYS’ industry-leading product development team focus entirely on method development for new contaminants and new matrices. AXYS’ expertise has been selected to develop analytical procedures for several regulatory bodies, focused on detecting some of the most difficult trace analyses of complex matrices.
Organochlorine Legacy Compounds
- Validation of Method 1668A (PCBs by HRMS) for U.S. EPA plus serum and blood matrices
Emerging Contaminants
- Development of Method 1614Draft (PBDEs by HRMS) for U.S. EPA plus serum and blood matrices
- Development of EPA Method 1694 for Pharmaceutical and Personnel Care Products ( 74 parameters) by LC/MS/MS (Water and Solids Matrices) for U.S. EPA
- Development of EPA Method 1698 for Hormones and Sterols (26 parameters) by GC HRMS (Water and Solids Matrices) for U.S. EPA
- Development of EPA Method 1699 for Multi- Residue Pesticides (64 parameters) by GC HRMS (Water, and Solid Matrices) for U.S. EPA
- Development of Method for Parabens in Serum by LC/MS/MS for a North American NGO organization
Specialty Analysis
- Development of Method for Acid Extractable Herbicides (8 parameters) by HRMS (Water and BioSolid Matrices) for U.S. EPA and Environment Canada
- Development of Method for Multi Residue Pesticides (79 parameters) by HRMS (Water and BioSolid Matrices) for U.S. EPA and Environment Canada
- Development of Method for Pyrethroid Pesticides (19 parameters) by HRMS (Water and Biosolid Matrices) for U.S. EPA
- Development of Method for combined Bisphenol A and Mono Phthalate Esters in Urine for U.S. Health Regulatory Agency by LC/MS/MS (current project)
- Development of Method for Triclosan in Serum by LC/MS/MS for U.S. a North American NGO organization
Return to Top
